Bhaskar Anand - 15 Aug 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role
SVP, Chief Accounting Officer
Signature
/s/ Tracy Herson, attorney-in-fact
Issuer symbol
N/A
Transactions as of
15 Aug 2023
Net transactions value
-$67,995
Form type
4
Filing time
17 Aug 2023, 16:31:39 UTC
Previous filing
16 Jun 2023
Next filing
07 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Sale $32,628 -193 -0.78% $169.06 24,705 15 Aug 2023 Direct F1
transaction RETA Class A common stock Sale $35,368 -210 -0.85% $168.42 24,495 16 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.